Investors have seemingly homed in on flat sales in the Watchman and electrophysiology segments of Boston’s cardio portfolio, prompting a stock fall.

Abbott's CardioMEMS sensor will now be available to patients with chronic heart failure through the NHS, as per NICE's ...

The trial’s endpoints focus on the procedural and clinical performance of the system for pulmonary embolism treatment, assessing right heart function. Credit ...

Medtronic has announced plans to exercise its option to acquire medical device company CathWorks, which is focused on ...

RevealDX has obtained US Food and Drug Administration (FDA) clearance for RevealAI-Lung, an artificial intelligence (AI)-based software for lung nodule risk assessment.

The Medicines and Healthcare products Regulatory Agency (MHRA) is formalising its review process around in vitro diagnostics (IVD) or companion diagnostics (CDx) used in clinical trials, with failure ...

Endospan has announced positive one-year results from the TRIOMPHE study evaluating its NEXUS aortic arch stent-graft system.

GE HealthCare has gained simultaneous US Food and Drug Administration (FDA) clearance and a European CE mark for Allia Moveo, ...

Medtronic has reported three milestones in the US, expanding access to its MiniMed 780G insulin delivery system for ...

Quest Diagnostics has introduced a new flow cytometry MRD blood test for myeloma, a cancer arising from abnormal plasma cells.

With the wearables market continuing to boom, smart patches could become the next big focus area for tracking healthcare ...

Siemens Healthineers has cut the red ribbon on a new €10m ($11.85m) centre of excellence focused on immunoassay instrument R&D in Swords, Ireland.